Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4053 versus cetirizine and placebo in seasonal allergic rhinitis
2012-002273-54Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing ONO-4053 sequence, cetirizine sequence and placebo sequence (3 arms). Started Oct 2012; status: completed.
02
Drugs
ONO-4053cetirizine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2012-002273-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002273-54.